Global Fish Vaccines Market

 

 

The Global Fish Vaccines Market was valued at USD 215 million in 2021 which expected to reach at USD 378 million by 2027 at a CAGR 10 % from 2022-2027.
 

Fish vaccines are specially used on fish. The culture environment, be it in tanks, cages/ponds, seawater or freshwater, can stress the fish due to reduced oxygen levels, high stocking densities, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases (bacterial, viral, fungal or parasitic in origin). These vaccines are the immune foundations for immunizing fish against various diseases.

 

 

Market Drivers

 

The increase in number of aquaculture farms is a prominent driving factor which expected to boost the growth of global fish vaccines market over the forecast period. Also, the increase in use of vaccines over antibiotics by fish farmers is expected to drive the growth of the global fish vaccines market.

 

Moreover, Market players are focused on strategies like acquisitions, which is expected to propel the growth of the global fish vaccines market over the forecast period. For instance, in December 2018, Phibro Animal Health Corp., a manufacturer of vaccines & medicated feed additives, acquired aquaculture vaccine maker KoVax Ltd. The acquisition strengthened the position of Phibro Animal Health Corp. in fish vaccine innovation & expanded its portfolio of aquaculture products.

 

 

Market Restraints

 

Factors causing failure in the efficiency of fish vaccination is expected to be major restraining factor which expected to hinder the growth of global fish vaccines market.

 

 

Market Segmentation

 

Global Fish Vaccines Market is segmented into Vaccine Type such as Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, Recombinant Vector Vaccines. By indication, market is segmented into Furunculosis, Vibriosis, Yersiniosis, Enteric septicaemia, Others. By Route of Administration, market is segmented into Injection, Immersion, Spray, Oral.

 

 

Regional Analysis

 

The Global Fish Vaccines Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

 

North America is expected to hold large market share for the fish vaccines market, due to increasing product launches/approvals of vaccines in the region. For instance, in November 2019, MSD Animal Health, a division of Merck & Co., Inc. which is headquartered in the United States, launched a new vaccine AQUAVAC Strep Sa-Si to protect against streptococcosis in fish which is indicated for the active immunization of tilapia (Oreochromis sp.) & other susceptible fish species, in order to reduce mortality and disease due to streptococcosis caused by Streptococcus agalactiae (serotype Ib) and Streptococcus iniae.

 

 

Key Players

 

VETERQUIMICA SA, Ictyogroup, Kyoto Biken Laboratories, Inc., HIPRA, Vaxxinova International BV, Barramundi Group, Merck & Co., Inc., Zoetis Inc., Aqua Vet S.A., NISSEIKEN CO., LTD., KBNP, INC., etc.

 

 

Market Taxonomy

 

By Vaccine Type

 

  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines

 

By Indication

 

 

By Route of Administration

 

 

By Region

 

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Global Fish Vaccines Market Toc

 

 

1 Introduction       


1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope

 

 

2 Research Methodology

 

2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources

 

 

3 Executive Summary
 

4 Global Fish Vaccines Market Outlook
 

4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

 

 

5 Global Fish Vaccines Market, By Vaccine Type
 

5.1 Y-o-Y Growth Comparison, By Vaccine Type

5.2 Global Fish Vaccines Market Share Analysis, By Vaccine Type

5.3 Global Fish Vaccines Market Size and Forecast, By Vaccine Type
5.3.1 Killed Vaccine

5.3.2. Inactivated Vaccine

5.3.3. Attenuated Vaccine

5.3.4. Toxoid Vaccine

5.3.5. Subunit Vaccine

5.3.6. Conjugate Vaccine

5.3.7. Recombinant Vector Vaccines

 

 

6 Global Fish Vaccines Market, By Indication
 

6.1 Y-o-Y Growth Comparison, By Indication

6.2 Global Fish Vaccines Market Share Analysis, By Indication

6.3 Global Fish Vaccines Market Size and Forecast, By Indication
6.3.1. Furunculosis

6.3.2 Vibriosis

6.3.3. Yersiniosis

6.3.4. Enteric septicaemia

6.3.5. Others

 

 

7 Global Fish Vaccines Market, By Route of Administration
 

7.1 Y-o-Y Growth Comparison, By Route of Administration

7.2 Global Fish Vaccines Market Share Analysis, By Route of Administration

7.3 Global Fish Vaccines Market Size and Forecast, By Route of Administration
7.3. 1. Injection

7.3.2. Immersion

7.3.3. Spray

7.3.4. Oral

 

 

8 Global Fish Vaccines Market, By Region
 

8.1 Global Fish Vaccines Market Share Analysis, By Region

8.2 Global Fish Vaccines Market Share Analysis, By Region

8.3 Global Fish Vaccines Market Size and Forecast, By Region

 

 

9 North America Fish Vaccines Market Analysis and Forecast (2022-2027)
 

9.1 Introduction

9.2 North America Fish Vaccines Market Share Analysis, By Vaccine Type

9.3 North America Fish Vaccines Market Size and Forecast, By Indication

9.4 North America Fish Vaccines Market Size and Forecast, By Route of Administration

9.5 North America Fish Vaccines Market Size and Forecast, By Country

9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico

 

 

10 Europe Fish Vaccines Market Analysis and Forecast (2022-2027)
 

10.1 Introduction

10.2 Europe Fish Vaccines Market Share Analysis, By Vaccine Type

10.3 Europe Fish Vaccines Market Size and Forecast, By Indication

10.4 Europe Fish Vaccines Market Size and Forecast, By Route of Administration

10.5 Europe Fish Vaccines Market Size and Forecast, By Country

10.5.1 Germany
10.5.2 France
10.5.3 UK

10.54. Rest of Europe

 

 

11 Asia Pacific Fish Vaccines Market Analysis and Forecast (2022-2027)
 

11.1 Introduction

11.2 Asia Pacific Fish Vaccines Market Share Analysis, By Vaccine Type

11.3 Asia Pacific Fish Vaccines Market Size and Forecast, By Indication

11.4 Asia Pacific Fish Vaccines Market Size and Forecast, By Route of Administration

11.5 Asia Pacific Fish Vaccines Market Size and Forecast, By Country

11.5.1 China    
11.5.2 Japan
11.5.3 India

11.5.4. Rest of Asia Pacific

 

 

12 Latin America Fish Vaccines Market Analysis and Forecast (2022-2027)
 

12.1 Introduction

12.2 Latin America Fish Vaccines Market Share Analysis, By Vaccine Type

12.3 Latin America Fish Vaccines Market Size and Forecast, By Indication

12.4 Latin America Fish Vaccines Market Size and Forecast, By Route of Administration

12.5 Latin America Fish Vaccines Market Size and Forecast, Country

12.5.1. Brazil

12.5.2. Rest of Latin America

 

 

13 Middle East Fish Vaccines Market Analysis and Forecast (2022-2027)
 

13.1 Introduction

 13.2 Middle East Fish Vaccines Market Share Analysis, By Vaccine Type

13.3 Middle East Fish Vaccines Market Size and Forecast, By Indication

13.4 Middle East Fish Vaccines Market Size and Forecast, By Route of Administration

13.5 Middle East Fish Vaccines Market Size and Forecast, By Country

13.5.1. Saudi Arabia

13.5.2. UAE

13.5.3. Egypt

13.5.4. Kuwait

13.5.5. South Africa

 

 

14 Competitive Analysis
 

14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies

 

 

15 Company Profiles

 

15.1 VETERQUIMICA SA

 

15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview

15.1.5 Key Market Developments

15.1.6 Key Strategies

 

 

15.2. Ictyogroup

 

15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview

15.2.5 Key Market Developments

15.2.6 Key Strategies

 

 

15.3. Kyoto Biken Laboratories, Inc

 

15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview

15.3.5 Key Market Developments

15.3.6 Key Strategies

 

 

15.4 HIPRA

 

15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview

15.4.5 Key Market Developments

15.4.6 Key Strategies

 

 

15.5 Vaxxinova International BV

 

15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview

15.5.5 Key Market Developments

15.5.6 Key Strategies

 

 

15.6 Barramundi Group
 

15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview

15.6.5 Key Market Developments

15.6.6 Key Strategies

 

 

15.7 Merck & Co., Inc

 

15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview

15.7.5 Key Market Developments

15.7.6 Key Strategies    

 

 

15.8 Zoetis Inc

 

15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview

15.8.5 Key Market Developments

15.8.6 Key Strategies

 

 

15.9 Aqua Vet S.A.

 

15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview

15.9.5 Key Market Developments

15.9.6 Key Strategies

 

 

15.10 NISSEIKEN CO., LTD

 

15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview

15.10.5 Key Market Developments

15.10.6 Key Strategies

 

 

15.11 KBNP, INC

 

15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview

15.11.5 Key Market Developments

15.11.6 Key Strategies